Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix

NCT07543757 is registered in ClinicalTrials.gov with Sequenom, Inc. as lead sponsor.

NCT NCT07543757
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07543757 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix
Lead sponsor
Sequenom, Inc.
Phase
Observational
Overall status
Recruiting
Start date
April 3, 2026
Completion date
March 31, 2027
Enrollment
500 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer detection